Renal ischemia-reperfusion (I/R) injury, which is unavoidable in renal transplantation, frequently influences both short-and long-term allograft survival. Despite decades of laboratory and clinical investigations, and the advent of renal replacement therapy, the overall mortality rate due to acute tubular injury has changed little. I/R-induced DNA damage results in p53 activation in proximal tubule cells (PTC), leading to their apoptosis. Therefore, we examined the therapeutic effect of temporary p53 inhibition in two rat renal transplantation models on structural and functional aspects of injury using intravital two-photon microscopy. Nephrectomized Sprague-Dawley rats received syngeneic left kidney transplantation either after 40 min of intentional warm ischemia or after combined 5-h cold and 30-min warm ischemia of the graft. Intravenously administrated siRNA for p53 (siP53) has previously been shown to be filtered and reabsorbed by proximal tubular epithelial cells following the warm ischemia/reperfusion injury in a renal clamp model. Here, we showed that it was also taken up by PTC following 5 h of cold ischemia. Compared to saline-treated recipients, treatment with siP53 resulted in conservation of renal function and significantly suppressed the I/Rinduced increase in serum creatinine in both kidney transplantation models. Intravital two-photon microscopy revealed that siP53 significantly ameliorated structural and functional damage to the kidney assessed by quantification of tubular cast formation and the number of apoptotic and necrotic tubular cells and by evaluation of blood flow rate. In conclusion, systemic administration of siRNA for p53 is a promising new approach to protect kidneys from I/R injury in renal transplantation.
INTRODUCTION
death in the form of apoptosis and/or necrosis (10, 30) . Although the relative importance of these two forms of cell death in determining the functional outcome of in-Clinical and experimental evidence suggest that ischemia-reperfusion (I/R) injury to kidney grafts may in-jury remains poorly understood, we demonstrated that preventing apoptosis is protective also against other fluence both early and late transplant function (29). Ischemia followed by reperfusion is closely related to the components of renal I/R injury (17, 27) . We and others have documented the importance of pathogenesis of early graft damage. Overall, ischemia in a kidney graft is the sum of possible transient warm is-p53 activation in I/R injury to the kidney and other organs (7) (8) (9) 15, 18, 19) . Moreover, we have demonstrated chemia during allograft removal from the donor and the transplantation operation, and cold ischemia associated that pharmacological inhibition of p53 using either small molecule (19) or systemically delivered small interfering with graft preservation and storage (28). Reperfusion, which is critical to the viability of the transplanted or-RNA (siRNA) targeting p53 (24) minimized acute I/R injury to the kidney in the renal clamp model. gan, induces additional damage (23) . I/R injury is characterized histologically by inflammation and tubular cell After systemic administration, siRNA tends to show accumulation in both the liver and kidneys (5) . We have using 10-0 Prolene (ETHICON, Somerville, NJ). The animals were rehydrated with 1 ml of sterile saline intro-shown extensive and predominant accumulation of siRNA with phosphodiester backbone in proximal tu-duced into the abdominal cavity. The muscle layer was closed with 3-0 silk; the skin was sutured with either bule cells (PTC). The internalized siRNA had relatively short tissue half-life and showed suppression of its tar-surgical staples or silk. Total warm ischemia time (including surgical procedures) was approximately 40 min. get, p53 (24) . Other investigative teams have also shown that antisense oligonucleotides and siRNA suppress ac-Syngeneic Kidney Transplantation Model (Cold Istivity of the target genes expressed in proximal tubular chemia Model). Donor male SD rats were anesthetized cells. Thus, suppression of renal Fas (26), caspase 3 and with 50 mg/kg pentobarbital sodium (Besse Scientific) 8 (33) , or C5a (34) have been shown to minimize ischebefore surgery. Anesthetized animals were subjected to mic injury in the kidney. a midline laparotomy. Left kidney was removed and From the first in vivo application of siRNA in an flushed via renal artery with an ice-cold preservation animal model (22), the pace of drug development has HTK solution (Custodiol; Riyadh, Saudi Arabia) and been more rapid when compared with antisense oligonuplaced on ice under sterile conditions for a period of 5 cleotides, which have been pursued as a therapeutic tool h. At the end of this period, a bilateral nephrectomy was for over 20 years. Therefore, the present studies were performed on a similarly anesthetized recipient rat, and undertaken to assess potential utility of siP53 previously the cold-preserved left kidney from a donor animal was used by us for renal protection in a clamp model, in transplanted into the recipient rat as described for kidney other clinically relevant models of renal I/R associated autotransplantation model. Additional warm ischemia with kidney transplantation. Functional analysis demonperiod for the graft during the surgery was approxistrated efficacy of siP53 in reducing posttransplantation mately 30 min. increases of serum creatinine levels. In addition, for the Serum Creatinine Measurements first time, we have employed intravital two-photon microscopy to examine the effect of siRNA for p53 in situ.
Blood samples (1 ml) were drawn from the tail vein We observed that administrated siRNA for p53 was deand centrifuged. The serum was collected and stored at livered into tubular epithelial cells by endocytosis fol-−20°C until the analysis. Creatinine concentrations were lowing glomerular filtration. It minimized PTC apoptomeasured using a Creatinine Analyzer 2 (Beckman Inc.). sis and tubular cast formation and preserved peritubular
The device was standardized with a corresponding commicrovascular blood flow. These studies demonstrate mon control, and the samples were run using a picric applicability of two-photon microscopy for quantificaacid reaction. tion of structural and functional changes associated with Two-Photon Microscopy and Image Analysis cellular injury in the kidneys and further emphasize potential therapeutic utility of siP53 in acute kidney injury All two-photon imaging was conducted as previously optimized and described (11, 25) . To study triply labeled indications.
samples the fluorescence emission were split into three channels centered at 605, 525, and 455 nm, collected in MATERIALS AND METHODS separate photomultiplier tube detectors, and displayed as Animal Models pure red, green, and blue, respectively. Stacks were col-Male Sprague-Dawley (SD) rats (230-280 g; Harlan, lected by 1-µm optical steps into the tissue to a maximal Indianapolis, IN) were used for all studies and cared for depth of 100 µm. Images and data volumes were proas previously described (1) . All protocols were approved cessed using Image J software (U. S. National Institutes by the Indiana University IACUC committee.
of Health, MD, http://rsb.info.nih.gov/ij/), Metamorph Image Processing Software (Universal Imaging-Molecu-Kidney Autotransplantation (Warm Ischemia Model). Male SD rats were anesthetized with 50 mg/kg pento-lar Devices, PA), and Adobe Photoshop (Adobe, CA) as previously reported (2) . Fluorescent siRNA uptake was barbital sodium (Besse Scientific, Louisville, KY) before surgery and placed on a homeothermic table to performed and imaged as previously described (24) . Fluorescent probes were infused via a jugular venous line maintain core body temperature at 37°C. Anesthetized animals were subjected to a midline laparotomy. Left or a femoral venous line. Fluorescent probes were injected in a bolus with normal saline in a total combined kidneys were harvested and placed in a dish containing 0.9% NaCl for a few minutes during which time a right volume not exceeding 0.5 ml. All probes obtained from Molecular Probes (Eugene, OR). Dyes included 500,000 nephrectomy was performed on the same animal. The left kidneys were then autotransplanted, being placed Da fluorescein dextran (green) for visualizing microvascular flow and organ perfusion; 10,000 Da rhodamine into their orthotopic position. End-to-end anastomoses of the renal artery, vein, and urether were performed dextran (red) or cascade blue dextran (blue) for visualiz-ing endocytosis by proximal tubules; Hoechst 33342 blocked with StartingBlock solution (Pierce, 350 µl/ well) at 37°C for 2 h. Then, the plates were again (cyan) labels all nuclei and allows for identification of apoptotic nuclei; and propidium iodide (PI, red) was washed three times with 300 µl/well PBS. Kidney protein extracts (0.2 mg) diluted in 1% BSA in PBS to a used to labels only necrotic nuclei. Nuclei appear white (red plus blue) when stained with both PI and Hoechst.
final volume of 100 µl were added to the wells and incubated at 25-27°C for 2 h. Unbound proteins were re-Quantification of Tubular Profiles Containing Cast moved by five repeated washings with 1× TBS contain-Material. There were 35-112 fields of view per animal ing 0.05% NP-40 (300 µl/well). Next, rabbit anti-p53 captured at 20× magnification. Number of cast-positive polyclonal antibodies FL-393 (Santa Cruz) were added tubular profiles were determined per field of view, sumto a final concentration of 5 µg/ml, in StartingBlock marized per animal, and averaged per field. These indi-(100 µl well) and incubated for 1 h at 37°C. Unbound vidual animal average values were then used to calculate antibodies were removed by five consecutive washes average number of positive profiles per view field per with 1× TBS containing 0.05% NP-40 (300 µl/well). group.
The detecting antibodies, goat-anti-rabbit F(ab′) 2 and Fc-Quantification of Apoptotic and Necrotic Cells in Tu-HRP (both from Jackson Laboratories) were diluted 1: bular Profiles. Apoptotic and necrotic nuclei were iden-10,000 in StartingBlock and added in a volume of 100 tified as previously described (20). The number of dead µl well. The plates were incubated for 1 h at 37°C. Uncells was estimated per area (view field) captured at 20× bound antibodies were removed by five consecutive magnification. There were 37-92 areas analyzed per anwashes of 1× TBS containing 0.05% NP-40 (300 µl/ imal, summarized per animal and averaged per field. well). The reaction was developed using QuantaBlu Flu-These individual animal average values were then used orogenic substrate kit (Pierce) according to the manufacto calculate average number of dead cell per view field turer's instructions. per group.
Renal Blood Flow. Renal blood flow was measured
Statistical Analysis using a modified line scan method (25,35) based on Statistical analysis was performed using SAS packevaluation of RBC speed rate. The evaluation was perage by a qualified statistician. Values are reported as formed in 20 randomly captured cortical fields, 5 ranmean ± SD. Statistical significance, defined as p < 0.01 domly captured line scans of horizontal vessels within or p < 0.05, was evaluated using the Tukey test for paraeach field, and both small and large diameter vessels metric multiple comparison. within the field of view were studied. The results were summarized per animal and averaged per field. RESULTS
Efficacy of Systemic Administration of siRNA Targeting p53 ELISA Assay p53 in Amelioration of I/R Injury in Kidney
The kidney was ground to powder by mortar and pes-Autotransplantation (Warm Ischemia) Model tle in liquid nitrogen. The powder was lyzed in an icecold lysis buffer 1 (0.1 M Tris, pH 7.5, 1 mM EDTA, 1
Six to 10 SD male rats per group were subjected to kidney autotransplantation operation as described in Ma-mM EGTA, 2 mM DTT, 20 mM NaF, 4 mM Na 4 P 2 O 7 , 4 mM b-glycerophosphate, 20 mM ZnSO 4 , 1 tablet of terials and Methods. Control animals were injected intravenously with 100 µl saline 15 min before kidney protease inhibitors per 20-ml solution). One gram of ground kidney tissue was mixed with 5 ml of buffer 1 removal (n = 10). Experimental groups received 12 mg/ kg siP53 as a 100-µl bolus intravenous injection either and then further homogenized using Pro2000 homogenizer for 5-10 s. The homogenate was incubated for 40 at 15 min before kidney removal ("15 min pre" group, n = 6) or at 4 h after kidney autotransplantation ("4 h min on ice while gently shaking. An equal volume of buffer 2 (20% glycerol, 800 mM NaCl) was added to post" group, n = 6), or both at 15 min before kidney removal and 4 h after its autotransplantation ("15 min the homogenate while gently vortexing. After a second cycle of incubation for 40 min on ice with gentle shak-pre + 4 h post" group, n = 7). siRNA dose and 4-h time point selection were based on the previous determination ing, the lysate was subjected to ultracentrifugation at 100,000 × g for 1 h at 40°. The cleared supernatant was of the optimal conditions for siP53 efficacy in the clamp I/R acute kidney injury model (24) . The animals from aliquoted and snap-frozen in liquid nitrogen until used.
For ELISA, black clear bottom plates were coated the latter group received a total of 24 mg/kg siP53 in two injections. Serum creatinine levels served to quan-with mouse anti-p53 MoAb DO-7 (Santa Cruz) in a carbonate buffer (100 µl/well), at a final concentration of 2 tify functional efficacy end point and were measured at 24 and 48 h and at 1 week after autotransplantation. In µg/ml, and incubated at 4°C overnight. The plates were washed three times with 300 µl/well PBS, and further the course of the study, kidneys of some randomly se-lected operated animals from all groups were subjected among the three different siRNA treatment regimes used, although the postoperation treatment seemed to be to intravital two-photon microscopy analysis. more effective than the preoperation one. siP53 Treatment Attenuates Serum Creatinine Increase siP53 Treatment Reduces Cast Occurrence Following Kidney Autotransplantation in the Transplanted Kidney In all siP53 treatment regimens tested, serum creati-Intravital two-photon analysis of tubular cell injury nine levels were lower than those in the control group was undertaken. As is shown in Figure 2 , remarkably ( Fig. 1) . Despite of the obviously lower serum creatinine more 10-kDa cascade blue dextran was endocytosed by levels in all siP53-treated groups, the difference between PTC in siRNA-treated rats (compare Fig. 2B vs. A). In each of the treatment groups and the control group at all SD rats, it is difficult to quantify PTC endocytosis as time points was not significant (adjusted value p > 0.90) the different tubular segments cannot be identified in when evaluated as repeated measurements. This effect these outer cortical fields. However, cast formation was was due to a rapid normalization of serum creatinine easily quantified and slowed markedly fewer casts in levels in the control group at 48-h and 1-week postoper-siRNA-treated rats (Fig. 2C ). Because these were termiation time points. Because serum creatinine levels in this nal studies, as nuclear marker dyes were used, the nummodel peaked at 24 h posttransplantation, followed by a ber of animals analyzed was limited. Comparison of quick normalization, the statistical differences between control group (n = 3) with all siP53-treated animals as a control and siP53 treatment groups were addressed indejoint group (n = 5) revealed statistically significant difpendently at the 24-h time point. As shown in Figure 1 , ference at 24 h after the transplantation (p < 0.01). At 1 at this time point all siRNA-treated groups had serum
week after the operation, the results for control and creatinine levels significantly lower than those in the treated groups did not show statistical difference due to control untreated transplant group. No significant differimprovement in control rats. ences in reduction of serum creatinine levels were found
siP53 Treatment Reduces Frequency of Apoptotic/ Necrotic Cells in the Transplanted Kidney
Intravital two-photon microscopy was also used to quantify apoptosis and necrosis in outer cortical PTC at 24 h posttransplantation. Again, administration of siRNA to p53 markedly reduced the combined number of apoptotic and necrotic cells (dead cells). All three siP53 treatment groups demonstrated a positive response and this difference was statistically different if a comparison was made between untreated (n = 3) and siRNA treated (n = 5) rats (p < 0.01) ( Fig. 3 ).
siP53 Treatment Improves Blood Flow in the Transplanted Kidney
Microvascular RBC flow rates were analyzed using line scan techniques, as we have previously reported (25, 35) . Microvessels of different diameter within a given random field were quantified. RBC flow rates were significantly improved by treatment with siRNA 4 higher than at baseline, they were only slightly elevated p53 protein levels in the treated groups were still above baseline (Fig. 5 ). (ϳ1.5-fold) in the extracts from groups treated with siP53. Because we have previously shown that RNAi in Efficacy of Systemic Administration of siRNA Targeting proximal tubular cells was relatively short (maximum 3 p53 in Amelioration of I/R Injury in Kidney days) (24), the observed difference in p53 protein levels Transplantation (Cold Ischemia) Model between saline-and siP53-treated groups at 1 week after administration rather has to be attributed to a lesser kid-Because in clinical practice donor kidneys are frequently subjected not only to warm but also to cold is-ney injury in siP53 groups compared to control. In fact, chemia prior to transplantation, we next studied the ef-constructed image comprising 10 planes is shown. Proximal tubule cells in each PT rapidly took up the red fect of systemic administration of siRNA targeting p53 in a cold ischemia model of kidney transplantation in fluorescent siRNA, but at variable levels. Figure 6C shows the serum creatinine results at 24, rats. Initial studies were conducted to document PTC uptake of siRNA with the previously described tech-48, and 168 h posttransplantation. Male SD rats (5-6 per group) were subjected to cold ischemia kidney trans-nique using Cy3-labeled siRNA (24) . In Figure 6A , a single confocal plane is shown, and in Figure 6B a re-plantation operation as described in Materials and Meth-ods. Control transplant recipients (n = 6) were injected spectively]. Serum creatinine levels served as the functional efficacy end point and were measured at 24 and intravenously with 100 µl saline 15 min after the restoration of blood flow in the graft. Experimental groups 48 h and at 1 week after the operation. The data analysis demonstrated that siP53 treatment given either to donors received 12 mg/kg siP53 as 100-µl bolus intravenous injection either to donors given at 30 min before kidney prior to kidney harvesting or to transplant recipients at either time point significantly reduced serum creatinine removal ("Donor 30 min" group; n = 6) or to recipients at 15 min or at 4 h after the transplantation ["Recipient levels as early as 24 h posttransplantation compared to the control group (Fig. 6C) . Although no significant dif-15 min" (n = 5) and "Recipient 4 h" (n = 6) groups, re- of injury or disease in target cells. We show here that the kidney, and in particular the proximal tubule epithelium, is a uniquely favorable target for synthetic siRNA accumulation and action following intravenous administration even after combined cold and warm ischemia of kidney graft. Effective siRNA delivery and therapeutic efficacy were achieved without the need for either local delivery into renal vessels, or systemic hydrodynamic administration as attempted before (16) or complicated formulation with delivery-enhancing agents.
In our previous study the use of two-photon fluorescence kidney imaging, with confirmation by in situ siRNA detection using hybridization, provided insight into the spatial and temporal distribution of the siRNA. localize the siRNA to specific cell types, and the distriprotein levels were assessed in kidney lysates using sandwich bution of labeled siRNA in the kidney could be followed ELISA. All ELISA reactions were performed twice on each protein extract. siP53 group contains animals treated with in the same animal over a time scale, giving information siRNA in all three regiments (pretreatment, posttreatment, and about the rate of metabolism of the siRNA. In the prescombination of both). Differences among all groups are statisent study we utilized intravital two-photon microscopy tically significant (p < 0.01). Data represent mean ± SD.
to evaluate and quantify tubular and microvasular injury as mechanisms of the reduced functional capacity of the kidney. Inhibition of p53 by siRNA resulted in fewer ferences were detected among all siP53 treatment apoptotic and necrotic cells, tubular casts, increased groups, it seems that siRNA administration to graft re-PTC endocytosis, and improved RBC flow rates. The cipients shortly after the transplantation was more effecpresent study also documented effectiveness of siRNA tive compared to donor treatment or to a delayed (at 4 h delivery and function following combined cold/warm isafter transplantation) recipient treatment. In contrast to chemia and reperfusion injury (Fig. 6 ). the autotransplantation warm ischemia model, exposure
The results of the present study prove that p53 is an of kidney grafts to cold ischemia prior to transplantation ideal therapeutic target in renal transplantation with I/R resulted in elevated (1.25 mg/dl) serum creatinine levels injury. I/R-induced tissue injury causes significant morin the control group even at 1 week posttransplantation, bidity and mortality in patients with renal disease. Tubuindicating delayed graft function ( Figs. 6C and 7) . At lar epithelial and endothelial cell death may contribute the same time, siP53-treated animals displayed a sharper to the hypoxic, as well as the reperfusion, components decline of serum creatinine that was almost twofold of this injury. These findings are in line with various in lower (around 0.6 mg/dl) than in untreated control rats at vivo and in vitro reports showing that renal apoptosis 1 week posttransplantation. This decrease occurred more after ischemia is induced by hypoxia (3) and ATP deplequickly in siP53-treated recipients compared to the tion (21). Furthermore, several studies suggest that group in which donors received siP53 treatment. In the upregulated p53, a transcription factor established for former groups serum creatinine was decreased to 0.7 apoptosis, senescence, and repair in response to a variety mg/dl already at 2 days after kidney transplantation. of cellular stress (12, 31) , is associated with I/R-induced cell death (19, 32) . DNA damage is sensed by the ataxia DISCUSSION telangiectasia mutated (ATM) and ATM and Rad3related (ATR) kinases. The signal is transmitted via The results of these studies add additional support to the therapeutic potential of the temporary inhibition of phosphorylation of CHEK2 (CHK2 checkpoint homolog) and p53. CHEK2 also directly phosphorylates p53. p53 expression to protect proximal tubule cells from acute injury, and further demonstrate that synthetic Activated p53 induces the transcription of genes responsible for cell cycle arrest and DNA repair. In the case of siRNAs represent an effective means for eliciting such activity in the kidney following intravenous administra-extensive DNA damage, apoptotic pathways are induced (6) . Therefore, temporary inhibition of p53 by siRNA tion. For these studies we utilized doses and timing strategies previously developed in a clamp model of ische-may be reasonable to protect kidneys from acute kidney injury in transplantation. mia (24) . Effective therapeutic use of siRNA depends on the ability to specifically suppress expression of target Oligonucleotides used in this present study were modified by 2′-O-methylation (24) , which effectively proteins, in target cells, contributing to the progression stabilized them against plasma endonucleases (13) , model, the increase at 24 h posttransplantation of serum creatinine had only decreased by 34% at 1 week post-while preserving their ability to trigger the RNAi silencing machinery. Oligonucleotides with this stabilizing transplantation ( Fig. 7) , clearly indicating the relevance of the cold ischemia model to delayed kidney graft func-modification have a relatively low affinity for albumin and other plasma proteins (14) , thus diminishing their tion. Thus, the combination of these two models allowed for the demonstration of the efficacy of siP53 treatment distribution to the liver and facilitating renal clearance/ uptake. in both preventing acute kidney failure and protecting kidneys from the delayed graft function. Two models of rat renal transplantation were utilized in this study. Warm ischemia/reperfusion alone or in Several aspects of the data presented here enhance and expand the potential clinical application of siRNA combination with a cold ischemia results in kidney damage that peaks at 24 h (Fig. 7 , red and blue diamonds).
for kidney transplantation indication. First, the kidney, and in particular the PTC, are overwhelmingly the pri-This similarity in kidney response continues till 48 h posttransplantation (Fig. 7 , red and blue circles). How-mary site of tissue distribution following intravenous injection even in the transplanted organ. Second, the rapid ever, at 1 week after the transplantation, there emerges a difference between the two models. Whereas kidney clearance from the body minimizes exposure of other organs/cells. Third, the optimum administration time of dysfunction caused by only warm ischemia/reperfusion disappeared by 1 week after the transplantation, addition siRNA (at least the one that targets p53) was found to be after the transplantation. This significantly simplifies of a cold ischemia period to the treatment scheme resulted in a delayed graft function (DGF) as shown by the use of the drug in clinical trials and in practice because only the transplant recipient would be treated and, serum creatinine levels remaining on average 1.25 mg/ dl compared to 0.6 mg/dl in only warm ischemia/reper-hence, only his/her consent is required. Altogether, the above observations indicate that syn-fusion model (Fig. 7 , blue and red triangles, respectively). According to a newly proposed definition of thetic siRNAs represent a very favorable strategy to achieve short-term inhibition of p53 expression in PTC DGF, it was described as an absence of spontaneous decrease in serum creatinine of more than 10% per day for to protect against ischemic injury that occurs during either warm or cold ischemia preceding kidney transplan-at least 3 consecutive days within the first week after transplantation (4) . Note that in control posttransplantion tation. These results, however, offer further insight into the utilization of siRNA for modulating proximal tubu-rats in the warm ischemia model, the initial serum creatinine increase at 24 h had decreased by 75% by the end lar cell events with particular emphasis on the inhibition of upregulation and amplification of potentially harmful of the first week, almost returning to the basal levels ( Figs. 1 and 7) . On the contrary, in the cold ischemia intracellular pathways.
